MIB-1 and S-phase cell fraction predict survival in non-Hodgkin's lymphomas
- 1 January 1997
- journal article
- Published by Wiley in Cell Proliferation
- Vol. 30 (1) , 37-47
- https://doi.org/10.1111/j.1365-2184.1997.tb00914.x
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Current status and future perspectives in the treatment of low-grade non-Hodgkin's lymphomasBlood Reviews, 1994
- MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.Journal of Clinical Pathology, 1994
- Cell proliferation as a long-term prognostic factor in diffuse large-cell lymphomasInternational Journal of Cancer, 1993
- Treatment of Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Comparison between the monoclonal antibodies Ki-67 and PC 10 in 125 malignant lymphomasThe Journal of Pathology, 1993
- Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathologyCytometry, 1993
- Prognostic implications of cell kinetics, histopathology and pathologic stage in non‐Hodgkin's lymphomasHematological Oncology, 1989
- Determination of proliferative fractions detected by immunohistochemistry with the monoclonal antibodies to bromodeoxyuridine and Ki-67 in malignant lymphomasHematological Oncology, 1989
- Comparative analysis of [3H]-thymidine labelling index and monoclonal antibody Ki-67 in non-Hodgkin's lymphomasHematological Oncology, 1987
- PROGNOSTIC RELEVANCE OF TUMOUR-CELL GROWTH FRACTION IN MALIGNANT NON-HODGKIN'S LYMPHOMASThe Lancet, 1987